InsidersTradesSigma
Vivani Medical, Inc.: directors' dealings · United States · SEC (Form 4)
Explore the full directors' dealings record of Vivani Medical, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €110.4m. The latest transaction was reported on 16 May 2025 (Acquisition). Among the most active insiders: Williams Gregg. All data is accessible without an account.
82
Insider Decl.
0
Thresholds
€6m
76 ops.
Buy Volume
·
0 ops.
Sell Volume
36Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 16 May 2025
Declarations82 total
3,499 shares@ US$1.010.1% of flowCommon StockSEC:0001753926-25-000860:0
Ideal exit: 8 Feb 2026 (T+270)
1,113 shares@ US$1.010.0% of flowCommon StockSEC:0001554855-25-000391:0
Ideal exit: 19 Jan 2026 (T+270)
1,569 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-25-000675:0
Ideal exit: 16 Jan 2026 (T+270)
18,529 shares@ US$1.020.3% of flowCommon StockSEC:0001753926-25-000620:0
Ideal exit: 4 Jan 2026 (T+270)
34,000 shares@ US$0.990.6% of flowCommon StockSEC:0001753926-25-000596:0
Ideal exit: 30 Dec 2025 (T+270)
2,000 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-25-000583:0
Ideal exit: 28 Dec 2025 (T+270)
4,000 shares@ US$1.0258.8% of flowCommon StockSEC:0001753926-25-000555:0
Ideal exit: 27 Dec 2025 (T+270)
1,000 shares@ US$1.112.5% of flowCommon StockSEC:0001753926-25-000392:0
Ideal exit: 25 Nov 2025 (T+270)
3,968,253 shares@ US$1.2687.2% of flowCommon StockSEC:0001753926-24-001875:0
Ideal exit: 5 Aug 2025 (T+270)
1,000 shares@ US$1.142.4% of flowCommon StockSEC:0001753926-24-001643:0
Ideal exit: 28 Jun 2025 (T+270)
5,000 shares@ US$1.2413.2% of flowCommon StockSEC:0001753926-24-001335:0
Ideal exit: 26 Apr 2025 (T+270)
2,000 shares@ US$0.964.1% of flowCommon StockSEC:0001753926-24-001334:0
Ideal exit: 18 Aug 2024 (T+270)
1,078 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-24-000345:0
Ideal exit: 11 Nov 2024 (T+270)
1,119 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-24-000261:0
Ideal exit: 4 Nov 2024 (T+270)
1,939 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-24-000224:0
Ideal exit: 1 Nov 2024 (T+270)
100 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-24-000210:0
Ideal exit: 27 Oct 2024 (T+270)
834 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-24-000164:0
Ideal exit: 19 Oct 2024 (T+270)
7,620 shares@ US$1.010.1% of flowCommon StockSEC:0001753926-24-000131:0
Ideal exit: 18 Oct 2024 (T+270)
999 shares@ US$1.010.0% of flowCommon StockSEC:0001753926-24-000128:0
Ideal exit: 14 Oct 2024 (T+270)
13,067 shares@ US$1.010.2% of flowCommon StockSEC:0001753926-24-000109:0
Ideal exit: 12 Oct 2024 (T+270)
6,731 shares@ US$1.080.1% of flowCommon StockSEC:0001753926-24-000081:0
Ideal exit: 4 Oct 2024 (T+270)
4,200 shares@ US$1.070.1% of flowCommon StockSEC:0001753926-24-000066:0
Ideal exit: 30 Sept 2024 (T+270)
3,548 shares@ US$1.010.1% of flowCommon StockSEC:0001753926-24-000055:0
Ideal exit: 28 Sept 2024 (T+270)
100 shares@ US$1.000.0% of flowCommon StockSEC:0001753926-23-001648:0
Ideal exit: 17 Sept 2024 (T+270)
198 shares@ US$0.860.0% of flowCommon StockSEC:0001753926-23-001621:0
Ideal exit: 14 Sept 2024 (T+270)
25 of 82 declarations